title: [Positron emission tomography of the thorax. The current clinical status].
abstract: The non-invasive diagnostic assessment of thoracic lesions has been greatly enhanced by the use of positron emission tomography with metabolic active radio-compounds such as fluor-18 labeled deoxyglucose. Four clinical fields of use were established: differential diagnostic evaluation of lesions (T-staging); classification of adenopathy (N-staging); therapy response monitoring; diagnostic evaluation of recurrence. The upcoming challenges for clinical use are limited availability and necessary technical and qualitative standardizations.
authors.affiliation: Forschungsschwerpunkt Radiologische Diagnostik und Therapie, Deutsches Krebsforschungszentrum, Heidelberg.
authors.forename: M V
authors.initials: MV
authors.lastname: Knopp
authors.forename: H
authors.initials: H
authors.lastname: Bischoff
authors.forename: F
authors.initials: F
authors.lastname: Oberdorfer
authors.forename: G
authors.initials: G
authors.lastname: van Kaick
mesh_terms: D002283:Carcinoma, Bronchogenic / Q000000981:diagnostic imaging*; D003847:Deoxyglucose / Q000031:analogs & derivatives; D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000000981:diagnostic imaging*; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging*; D014055:Tomography, Emission-Computed / Q000379:methods*
chemical_list: D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose
vernacular_title: Positronenemissionstomographie des Thorax. Derzeitiger klinischer Stellenwert.